
Cell Therapy Process Development Intern
AstraZeneca
Summary
We are looking for Master's and doctoral students studying Chemical/Mechanical/Biomedical Engineering, Pharmaceutical Sciences, or a related field for a 12-week internship role at our site in Gaithersburg, MD from May 24, 2027 to August 13, 2027.
Job description
Position Description
- Heat transfer modelling using computational tool
- Statistical analysis using JMP and/or Excel
- Cell culture and aseptic laboratory techniques
- T cell Cryopreservation and cryobiology fundamentals
- Technical problem-solving and troubleshooting
- Scientific documentation and technical report writing
Position Requirements
- Master's and doctoral students studying Chemical/Mechanical/Biomedical Engineering, Pharmaceutical Sciences, or a related field.
- Coursework or laboratory experience in biomedical engineering, chemical engineering, mechanical engineering, biotechnology, biology, or a related discipline.
- Basic understanding of heat transfer, thermodynamics, or transport phenomena, particularly as applied to freezing or temperature-controlled processes. Familiarity with COMSOL heat transfer module.
- Experience to cell culture, aseptic technique, cell-based assays, or general biological laboratory techniques.
- Experience with quantitative data analysis and visualization using tools such as Microsoft Excel, JMP, MATLAB, Python, or similar software.
- Familiarity with T cell cryopreservation, controlled rate freezing, cell therapy, or biopharmaceutical process development is desirable but not required.
- Experience with prototype development, engineering design, CAD, or fabrication would be beneficial for the device-development aspects of the project.
- Strong problem-solving and troubleshooting skills, with an interest in translating scientific principles into practical engineering solutions.
- Ability to document experimental work, interpret results, and communicate technical findings through written reports and presentations.
- Candidates must have an expected graduation date after August 2027.
- US Work Authorization is required at time of application.
- This role will not be granting OPT support.
- Ability to report onsite to Gaithersburg, MD site 5 days per week.
Requirements
- Master's or doctoral student in Chemical/Mechanical/Biomedical Engineering, Pharmaceutical Sciences, or related field
- Coursework or laboratory experience in biomedical engineering, chemical engineering, mechanical engineering, biotechnology, biology, or related discipline
- Basic understanding of heat transfer, thermodynamics, or transport phenomena
- Familiarity with COMSOL heat transfer module
- Experience with cell culture, aseptic technique, cell-based assays, or general biological laboratory techniques
- Experience with quantitative data analysis and visualization using Excel, JMP, MATLAB, Python, or similar software
- Strong problem-solving and troubleshooting skills
- Ability to document experimental work and communicate technical findings
- Expected graduation date after August 2027
- US Work Authorization required at time of application
- No OPT support
- Ability to report onsite to Gaithersburg, MD 5 days per week
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.